Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 5, 2010, Pages 757-766

  Ussia, Gian Paolo ^a,b   Scarabelli, Marilena ^a   Mulè, Massimiliano ^a   Barbanti, Marco ^a   Cammalleri, Valeria ^a   Immè, Sebastiano ^a   Aruta, Patrizia ^a   Pistritto, Anna Maria ^a   Carbonaro, Alessandro ^a   Deste, Wanda ^a   Sciuto, Paolo ^c   Licciardello, Giovanni ^a   Calvi, Valeria ^a   Tamburino, Corrado ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Excellence Through Newest Advances ETNA Foundation   (Italy)

^c Ferrarotto Hospital   (Italy)

Author keywords

aortic stenosis; cardiac intensive care unit; complications; percutaneous

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; ARTERY RECONSTRUCTION; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; FLUID BALANCE; HEART RHYTHM; HEART VALVE BIOPROSTHESIS; HEART VENTRICLE PERFORATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANEURYSM, FALSE; AORTIC VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; BIOPROSTHESIS; BUNDLE-BRANCH BLOCK; CARDIAC PACING, ARTIFICIAL; CARDIOVASCULAR DISEASES; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEART INJURIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ITALY; MALE; PERICARDIOCENTESIS; PROSTHESIS DESIGN; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78349250613     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22602     Document Type: Article

References (25)

1. Zajarias A, Cribier AG,. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009; 53: 1829-1836.
2. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, Devarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, Delarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E,. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
3. Piazza N, Grube E, Gerckens U, Den Heijer P, Linke A, Luha O, Ramondo AB, Ussia GP, Wenaweser P, Windecker S, Laborde JC, De Jaegere P, Serruys PW,: on the behalf of the clinical centres who actively participated in the registry. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: Results from the multicentre, expanded\evaluation registry 1-year following CE mark approval. EuroInterv 2008; 4: 242-249.
4. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U,. Progress and current status of percutaneous aortic valve replacement: Results of three device generations of the CoreValve® revalving system. Circ Cardiovasc Intervent 2008; 1: 167-175.
5. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L,. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15: 816-822.
6. Vassiliades TA Jr, Block PC, Cohn LH, Adams DH, Borer JS, Feldman T, Holmes DR, Laskey WK, Lytle BW, Mack MJ, Williams DO,; Society of Thoracic Surgeons (STS); American Association for Thoracic Surgery (AATS); Society for Cardiovascular Angiography and Interventions (SCAI); American College of Cardiology Foundation (ACCF); American Heart Association (AHA). The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS) and the Society for Cardiovascular Angiography and Interventions (SCAI). Ann Thorac Surg 2005; 79: 1812-1818.
7. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pièrard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T,. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 11: 1463-1470.
8. Tamburino C, Capodanno D, Mulè M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia GP,. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009; 21: 93-98.
9. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ,. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135: 180-187.
10. Wendt D, Osswald BR, Kayser K, Thielmann M, Tossios P, Massoudy P, Kamler M, Jakob H,. Society of thoracic surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg 2009; 88: 468-475.
11. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G,. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
12. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W,. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184.
13. Birck R, Kzossok S, Markowetz F, Schnulle P, Van der Woude FJ, Braun C,. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003; 362: 598-603.
14. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, RoSkamm H,. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336.
15. Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Elia PP, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B,. Standard vs. double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004; 25: 206-211.
16. Engelman R, Shahian D, Shemin R, Guy TS, Bratzler T, Edwards F, Jacobs M, Fernando H, Bridges C,. The society of thoracic surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery. Part II: Antibiotics choice. Ann Thorac Surg 2007; 83: 1569-1576.
17. Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, Bonato R, Pittarello D, Isabella G, Iliceto S, Ramondo A,. Expanding the eligibility for transcatheter aortic valve implantation: The trans-subclavian retrograde approach using the III generation CoreValve revalving system. J Am Coll Cardiol Interv 2009; 2: 828-833.
18. Bellomo R, Kellum JA, Ronco C,. Defining and classifying acute renal failure: From advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007; 33: 409-413.
19. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, Masson JB, Gutierrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodes- Cabau J,. Acute kidney injury following transcatheter aortic valve implantation: Predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010; 31: 864-874.
20. Ussia GP, Mulè M, Tamburino C,. The valve-in-valve technique: Transcatheter treatment of aortic bioprothesis malposition. Catheter Cardiovasc Interv 2009; 73: 713-716.
21. Fellmeth BD, Roberts AC, Bookstein JJ, et al. Postangiographic femoral artery injuries: Nonsurgical repair with US-guided compression. Radiology 1991; 178: 671-675.
22. Friedemann S, Worlfram T, Raymonde B, Michael H, Makarios P, Albert S,. Management of 219 consecutive cases of postcatheterization pseudoaneurysm. J Am Coll Cardiol 1997; 30: 670-675.
23. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW,. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008; 1: 310-316.
24. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW,. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624.
25. Shantsila E, Lip GYH, Chong BH,. Heparin-induced thrombocytopenia. Chest 2009; 135: 1651-1664.